iCoreConnect Inc.
iCoreConnect Inc. ICCT Peers
See (ICCT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICCT | $0.17 | -33.04% | 829.1K | N/A | -$45.78 | N/A |
| VEEV | $284.45 | +0.67% | 46.5B | 60.52 | $4.70 | N/A |
| GEHC | $72.86 | +0.84% | 33.4B | 15.31 | $4.76 | +0.18% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.18% |
| DOCS | $55.99 | +0.13% | 10.5B | 50.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $101.08 | -3.51% | 8.7B | 73.78 | $1.37 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSGU | $75.40 | -0.30% | 3.8B | N/A | N/A | N/A |
| BTSG | $21.32 | +0.66% | 3.7B | 78.96 | $0.27 | N/A |
Stock Comparison
ICCT vs VEEV Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, VEEV has a market cap of 46.5B. Regarding current trading prices, ICCT is priced at $0.17, while VEEV trades at $284.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 60.52. In terms of profitability, ICCT's ROE is -14.51%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, ICCT is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs GEHC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, GEHC has a market cap of 33.4B. Regarding current trading prices, ICCT is priced at $0.17, while GEHC trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 15.31. In terms of profitability, ICCT's ROE is -14.51%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, ICCT is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs GEHCV Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ICCT is priced at $0.17, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, ICCT is more volatile compared to GEHCV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs DOCS Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, DOCS has a market cap of 10.5B. Regarding current trading prices, ICCT is priced at $0.17, while DOCS trades at $55.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 50.44. In terms of profitability, ICCT's ROE is -14.51%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, ICCT is more volatile compared to DOCS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SGFY Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ICCT is priced at $0.17, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ICCT's ROE is -14.51%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ICCT is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs HQY Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, HQY has a market cap of 8.7B. Regarding current trading prices, ICCT is priced at $0.17, while HQY trades at $101.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 73.78. In terms of profitability, ICCT's ROE is -14.51%, compared to HQY's ROE of +0.06%. Regarding short-term risk, ICCT is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs RCM Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ICCT is priced at $0.17, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, ICCT's ROE is -14.51%, compared to RCM's ROE of -0.02%. Regarding short-term risk, ICCT is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BTSGU Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BTSGU has a market cap of 3.8B. Regarding current trading prices, ICCT is priced at $0.17, while BTSGU trades at $75.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, ICCT is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BTSG Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BTSG has a market cap of 3.7B. Regarding current trading prices, ICCT is priced at $0.17, while BTSG trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 78.96. In terms of profitability, ICCT's ROE is -14.51%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, ICCT is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs ONEM Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ICCT is priced at $0.17, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ICCT's ROE is -14.51%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ICCT is more volatile compared to ONEM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PRVA Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, ICCT is priced at $0.17, while PRVA trades at $22.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 190.75. In terms of profitability, ICCT's ROE is -14.51%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, ICCT is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs WGS Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, ICCT is priced at $0.17, while WGS trades at $66.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas WGS's P/E ratio is -48.12. In terms of profitability, ICCT's ROE is -14.51%, compared to WGS's ROE of -0.17%. Regarding short-term risk, ICCT is more volatile compared to WGS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PINC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PINC has a market cap of 1.8B. Regarding current trading prices, ICCT is priced at $0.17, while PINC trades at $22.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PINC's P/E ratio is 21.86. In terms of profitability, ICCT's ROE is -14.51%, compared to PINC's ROE of +0.03%. Regarding short-term risk, ICCT is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PGNY Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PGNY has a market cap of 1.8B. Regarding current trading prices, ICCT is priced at $0.17, while PGNY trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 36.95. In terms of profitability, ICCT's ROE is -14.51%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, ICCT is more volatile compared to PGNY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CERT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CERT has a market cap of 1.7B. Regarding current trading prices, ICCT is priced at $0.17, while CERT trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CERT's P/E ratio is -538.00. In terms of profitability, ICCT's ROE is -14.51%, compared to CERT's ROE of -0.00%. Regarding short-term risk, ICCT is more volatile compared to CERT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs NXGN Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ICCT is priced at $0.17, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ICCT's ROE is -14.51%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ICCT is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs GDRX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, GDRX has a market cap of 1.6B. Regarding current trading prices, ICCT is priced at $0.17, while GDRX trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 63.36. In terms of profitability, ICCT's ROE is -14.51%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, ICCT is more volatile compared to GDRX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SDGR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SDGR has a market cap of 1.6B. Regarding current trading prices, ICCT is priced at $0.17, while SDGR trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SDGR's P/E ratio is -8.06. In terms of profitability, ICCT's ROE is -14.51%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, ICCT is more volatile compared to SDGR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PHR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PHR has a market cap of 1.5B. Regarding current trading prices, ICCT is priced at $0.17, while PHR trades at $25.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PHR's P/E ratio is -34.96. In terms of profitability, ICCT's ROE is -14.51%, compared to PHR's ROE of -0.23%. Regarding short-term risk, ICCT is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs TXG Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, TXG has a market cap of 1.4B. Regarding current trading prices, ICCT is priced at $0.17, while TXG trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -8.47. In terms of profitability, ICCT's ROE is -14.51%, compared to TXG's ROE of -0.22%. Regarding short-term risk, ICCT is more volatile compared to TXG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs OMCL Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, OMCL has a market cap of 1.4B. Regarding current trading prices, ICCT is priced at $0.17, while OMCL trades at $29.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 63.52. In terms of profitability, ICCT's ROE is -14.51%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, ICCT is more volatile compared to OMCL. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs AGTI Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ICCT is priced at $0.17, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ICCT's ROE is -14.51%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, ICCT is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs TDOC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, ICCT is priced at $0.17, while TDOC trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -1.19. In terms of profitability, ICCT's ROE is -14.51%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, ICCT is more volatile compared to TDOC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs EVH Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, EVH has a market cap of 961.5M. Regarding current trading prices, ICCT is priced at $0.17, while EVH trades at $8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas EVH's P/E ratio is -6.71. In terms of profitability, ICCT's ROE is -14.51%, compared to EVH's ROE of -0.11%. Regarding short-term risk, ICCT is more volatile compared to EVH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs HSTM Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, HSTM has a market cap of 839.8M. Regarding current trading prices, ICCT is priced at $0.17, while HSTM trades at $27.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 43.67. In terms of profitability, ICCT's ROE is -14.51%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, ICCT is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs NUTX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, NUTX has a market cap of 743.1M. Regarding current trading prices, ICCT is priced at $0.17, while NUTX trades at $133.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas NUTX's P/E ratio is 10.82. In terms of profitability, ICCT's ROE is -14.51%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, ICCT is more volatile compared to NUTX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CTEV Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CTEV has a market cap of 657.1M. Regarding current trading prices, ICCT is priced at $0.17, while CTEV trades at $39.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -0.55. In terms of profitability, ICCT's ROE is -14.51%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, ICCT is more volatile compared to CTEV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MPLN-WT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ICCT is priced at $0.17, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, ICCT is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for ICCT.
ICCT vs ACCD Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ICCT is priced at $0.17, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ICCT's ROE is -14.51%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, ICCT is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SHCR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ICCT is priced at $0.17, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ICCT's ROE is -14.51%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, ICCT is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs DH Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, DH has a market cap of 403.6M. Regarding current trading prices, ICCT is priced at $0.17, while DH trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas DH's P/E ratio is -0.85. In terms of profitability, ICCT's ROE is -14.51%, compared to DH's ROE of -1.07%. Regarding short-term risk, ICCT is more volatile compared to DH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SLGCW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ICCT is priced at $0.17, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ICCT's ROE is -14.51%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ICCT is more volatile compared to SLGCW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SLGC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ICCT is priced at $0.17, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ICCT's ROE is -14.51%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ICCT is more volatile compared to SLGC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SLP Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SLP has a market cap of 381.1M. Regarding current trading prices, ICCT is priced at $0.17, while SLP trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 52.64. In terms of profitability, ICCT's ROE is -14.51%, compared to SLP's ROE of +0.04%. Regarding short-term risk, ICCT is more volatile compared to SLP. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs NRC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, NRC has a market cap of 379.6M. Regarding current trading prices, ICCT is priced at $0.17, while NRC trades at $16.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 16.33. In terms of profitability, ICCT's ROE is -14.51%, compared to NRC's ROE of +0.71%. Regarding short-term risk, ICCT is more volatile compared to NRC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MPLN Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ICCT is priced at $0.17, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ICCT's ROE is -14.51%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, ICCT is more volatile compared to MPLN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs TBRG Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, TBRG has a market cap of 350.8M. Regarding current trading prices, ICCT is priced at $0.17, while TBRG trades at $23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is -19.14. In terms of profitability, ICCT's ROE is -14.51%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, ICCT is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SPOK Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SPOK has a market cap of 338.8M. Regarding current trading prices, ICCT is priced at $0.17, while SPOK trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 21.39. In terms of profitability, ICCT's ROE is -14.51%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, ICCT is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs TRHC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ICCT is priced at $0.17, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ICCT's ROE is -14.51%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ICCT is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs HCAT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, HCAT has a market cap of 270.1M. Regarding current trading prices, ICCT is priced at $0.17, while HCAT trades at $3.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is -3.37. In terms of profitability, ICCT's ROE is -14.51%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, ICCT is more volatile compared to HCAT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs OPRX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, OPRX has a market cap of 254.7M. Regarding current trading prices, ICCT is priced at $0.17, while OPRX trades at $13.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is -16.39. In terms of profitability, ICCT's ROE is -14.51%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, ICCT is more volatile compared to OPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SMFR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ICCT is priced at $0.17, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, ICCT is more volatile compared to SMFR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SOPH Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SOPH has a market cap of 193.1M. Regarding current trading prices, ICCT is priced at $0.17, while SOPH trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -2.89. In terms of profitability, ICCT's ROE is -14.51%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, ICCT is more volatile compared to SOPH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs EUDA Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, EUDA has a market cap of 134.1M. Regarding current trading prices, ICCT is priced at $0.17, while EUDA trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -6.69. In terms of profitability, ICCT's ROE is -14.51%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, ICCT is more volatile compared to EUDA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CPSI Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ICCT is priced at $0.17, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ICCT's ROE is -14.51%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, ICCT is more volatile compared to CPSI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SY Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SY has a market cap of 123.7M. Regarding current trading prices, ICCT is priced at $0.17, while SY trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SY's P/E ratio is -1.17. In terms of profitability, ICCT's ROE is -14.51%, compared to SY's ROE of -0.26%. Regarding short-term risk, ICCT is more volatile compared to SY. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs AUGX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ICCT is priced at $0.17, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ICCT's ROE is -14.51%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, ICCT is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs AMWL Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, AMWL has a market cap of 110M. Regarding current trading prices, ICCT is priced at $0.17, while AMWL trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -0.69. In terms of profitability, ICCT's ROE is -14.51%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, ICCT is more volatile compared to AMWL. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CCLDO Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CCLDO has a market cap of 94.4M. Regarding current trading prices, ICCT is priced at $0.17, while CCLDO trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, ICCT is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CCLD Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CCLD has a market cap of 90.1M. Regarding current trading prices, ICCT is priced at $0.17, while CCLD trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is -9.68. In terms of profitability, ICCT's ROE is -14.51%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, ICCT is more volatile compared to CCLD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs FORA Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, FORA has a market cap of 62.7M. Regarding current trading prices, ICCT is priced at $0.17, while FORA trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -16.75. In terms of profitability, ICCT's ROE is -14.51%, compared to FORA's ROE of -0.13%. Regarding short-term risk, ICCT is more volatile compared to FORA. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BEATW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BEATW has a market cap of 60.4M. Regarding current trading prices, ICCT is priced at $0.17, while BEATW trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.85. In terms of profitability, ICCT's ROE is -14.51%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, ICCT is more volatile compared to BEATW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CCLDP Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ICCT is priced at $0.17, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, ICCT is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BEAT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BEAT has a market cap of 57.8M. Regarding current trading prices, ICCT is priced at $0.17, while BEAT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BEAT's P/E ratio is -2.31. In terms of profitability, ICCT's ROE is -14.51%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, ICCT is more volatile compared to BEAT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SNCE Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ICCT is priced at $0.17, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ICCT's ROE is -14.51%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ICCT is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs AKLI Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ICCT is priced at $0.17, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ICCT's ROE is -14.51%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, ICCT is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SHLT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ICCT is priced at $0.17, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ICCT's ROE is -14.51%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, ICCT is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SHCRW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ICCT is priced at $0.17, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ICCT's ROE is -14.51%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, ICCT is more volatile compared to SHCRW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs RNLX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ICCT is priced at $0.17, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ICCT's ROE is -14.51%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, ICCT is more volatile compared to RNLX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs LIFW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ICCT is priced at $0.17, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ICCT's ROE is -14.51%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs STRM Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, STRM has a market cap of 22.3M. Regarding current trading prices, ICCT is priced at $0.17, while STRM trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.04. In terms of profitability, ICCT's ROE is -14.51%, compared to STRM's ROE of -0.68%. Regarding short-term risk, ICCT is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BFRGW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BFRGW has a market cap of 22.2M. Regarding current trading prices, ICCT is priced at $0.17, while BFRGW trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to BFRGW's ROE of -1.33%. Regarding short-term risk, ICCT is more volatile compared to BFRGW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MGRX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MGRX has a market cap of 19M. Regarding current trading prices, ICCT is priced at $0.17, while MGRX trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.41. In terms of profitability, ICCT's ROE is -14.51%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, ICCT is more volatile compared to MGRX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs VSEEW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, VSEEW has a market cap of 17.7M. Regarding current trading prices, ICCT is priced at $0.17, while VSEEW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, ICCT is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs VSEE Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, VSEE has a market cap of 16.6M. Regarding current trading prices, ICCT is priced at $0.17, while VSEE trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -13.25. In terms of profitability, ICCT's ROE is -14.51%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, ICCT is more volatile compared to VSEE. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BFRG Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BFRG has a market cap of 16.5M. Regarding current trading prices, ICCT is priced at $0.17, while BFRG trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -2.19. In terms of profitability, ICCT's ROE is -14.51%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, ICCT is more volatile compared to BFRG. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs BBLN Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ICCT is priced at $0.17, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ICCT's ROE is -14.51%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ICCT is more volatile compared to BBLN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SCNX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SCNX has a market cap of 14M. Regarding current trading prices, ICCT is priced at $0.17, while SCNX trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is 1.62. In terms of profitability, ICCT's ROE is -14.51%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, ICCT is more volatile compared to SCNX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs INOV Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, INOV has a market cap of 12.6M. Regarding current trading prices, ICCT is priced at $0.17, while INOV trades at $31.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas INOV's P/E ratio is 16.29. In terms of profitability, ICCT's ROE is -14.51%, compared to INOV's ROE of +0.03%. Regarding short-term risk, ICCT is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MSPR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MSPR has a market cap of 12.1M. Regarding current trading prices, ICCT is priced at $0.17, while MSPR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MSPR's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to MSPR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs ONMD Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ONMD has a market cap of 11.8M. Regarding current trading prices, ICCT is priced at $0.17, while ONMD trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -1.14. In terms of profitability, ICCT's ROE is -14.51%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, ICCT is more volatile compared to ONMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs HCTI Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, HCTI has a market cap of 10.8M. Regarding current trading prices, ICCT is priced at $0.17, while HCTI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.03. In terms of profitability, ICCT's ROE is -14.51%, compared to HCTI's ROE of +2.95%. Regarding short-term risk, ICCT is more volatile compared to HCTI. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs ETAO Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ICCT is priced at $0.17, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ICCT's ROE is -14.51%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ICCT is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for ICCT.
ICCT vs HLTH Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, ICCT is priced at $0.17, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is -0.02. In terms of profitability, ICCT's ROE is -14.51%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, ICCT is more volatile compared to HLTH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs ZCMD Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ZCMD has a market cap of 6.4M. Regarding current trading prices, ICCT is priced at $0.17, while ZCMD trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -10.17. In terms of profitability, ICCT's ROE is -14.51%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, ICCT is more volatile compared to ZCMD. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs OTRK Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, OTRK has a market cap of 6M. Regarding current trading prices, ICCT is priced at $0.17, while OTRK trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.08. In terms of profitability, ICCT's ROE is -14.51%, compared to OTRK's ROE of -1.76%. Regarding short-term risk, ICCT is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs UPH Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ICCT is priced at $0.17, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, ICCT's ROE is -14.51%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ICCT is more volatile compared to UPH. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs EUDAW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, EUDAW has a market cap of 4.3M. Regarding current trading prices, ICCT is priced at $0.17, while EUDAW trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, ICCT is less volatile compared to EUDAW. This indicates potentially lower risk in terms of short-term price fluctuations for ICCT.
ICCT vs ACON Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ACON has a market cap of 4.3M. Regarding current trading prices, ICCT is priced at $0.17, while ACON trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.64. In terms of profitability, ICCT's ROE is -14.51%, compared to ACON's ROE of -1.27%. Regarding short-term risk, ICCT is more volatile compared to ACON. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PEARW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ICCT is priced at $0.17, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ICCT's ROE is -14.51%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ICCT is more volatile compared to PEARW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs PEAR Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ICCT is priced at $0.17, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ICCT's ROE is -14.51%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ICCT is more volatile compared to PEAR. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs WORX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, WORX has a market cap of 1.7M. Regarding current trading prices, ICCT is priced at $0.17, while WORX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.51. In terms of profitability, ICCT's ROE is -14.51%, compared to WORX's ROE of -0.32%. Regarding short-term risk, ICCT is more volatile compared to WORX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CMAX Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ICCT is priced at $0.17, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ICCT's ROE is -14.51%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, ICCT is more volatile compared to CMAX. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs FOXO Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, FOXO has a market cap of 1.4M. Regarding current trading prices, ICCT is priced at $0.17, while FOXO trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas FOXO's P/E ratio is -0.03. In terms of profitability, ICCT's ROE is -14.51%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, ICCT is more volatile compared to FOXO. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs LIFWZ Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ICCT is priced at $0.17, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs WGSWW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, WGSWW has a market cap of 1.1M. Regarding current trading prices, ICCT is priced at $0.17, while WGSWW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, ICCT is more volatile compared to WGSWW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs OTRKP Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, OTRKP has a market cap of 1M. Regarding current trading prices, ICCT is priced at $0.17, while OTRKP trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, ICCT's ROE is -14.51%, compared to OTRKP's ROE of -1.76%. Regarding short-term risk, ICCT is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs KERNW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ICCT is priced at $0.17, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ICCT's ROE is -14.51%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, ICCT is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for ICCT.
ICCT vs KERN Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ICCT is priced at $0.17, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, ICCT's ROE is -14.51%, compared to KERN's ROE of -2.22%. Regarding short-term risk, ICCT is more volatile compared to KERN. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MSPRZ Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MSPRZ has a market cap of 109.8K. Regarding current trading prices, ICCT is priced at $0.17, while MSPRZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs LIFWW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ICCT is priced at $0.17, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CMAXW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ICCT is priced at $0.17, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, ICCT is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs ACONW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, ACONW has a market cap of 20.8K. Regarding current trading prices, ICCT is priced at $0.17, while ACONW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is -0.01. In terms of profitability, ICCT's ROE is -14.51%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, ICCT is more volatile compared to ACONW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MSPRW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MSPRW has a market cap of 9K. Regarding current trading prices, ICCT is priced at $0.17, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MSPRW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, ICCT is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs UTRS Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, UTRS has a market cap of 888. Regarding current trading prices, ICCT is priced at $0.17, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas UTRS's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, ICCT is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MTBCP Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ICCT is priced at $0.17, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MTBCP's ROE of +0.21%. Regarding short-term risk, ICCT is more volatile compared to MTBCP. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs SMFRW Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ICCT is priced at $0.17, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to SMFRW's ROE of -0.17%. Regarding short-term risk, ICCT is more volatile compared to SMFRW. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs CSLT Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, ICCT is priced at $0.17, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, ICCT's ROE is -14.51%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, ICCT is more volatile compared to CSLT. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.
ICCT vs MTBC Comparison
ICCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICCT stands at 829.1K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ICCT is priced at $0.17, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICCT currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, ICCT's ROE is -14.51%, compared to MTBC's ROE of +0.21%. Regarding short-term risk, ICCT is more volatile compared to MTBC. This indicates potentially higher risk in terms of short-term price fluctuations for ICCT.